Cormedix Inc (CRMD)
5.445
+0.16
(+3.12%)
USD |
NASDAQ |
Apr 23, 16:00
5.445
0.00 (0.00%)
After-Hours: 18:27
Cormedix Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 0.0654M |
September 30, 2022 | 0.0921M |
June 30, 2022 | 0.1234M |
March 31, 2022 | 0.1103M |
December 31, 2021 | 0.1909M |
September 30, 2021 | 0.1903M |
June 30, 2021 | 0.2452M |
March 31, 2021 | 0.2534M |
December 31, 2020 | 0.2392M |
September 30, 2020 | 0.2083M |
June 30, 2020 | 0.1748M |
March 31, 2020 | 0.1936M |
December 31, 2019 | 0.2833M |
September 30, 2019 | 0.285M |
June 30, 2019 | 0.598M |
March 31, 2019 | 0.5703M |
December 31, 2018 | 0.4298M |
Date | Value |
---|---|
September 30, 2018 | 0.4958M |
June 30, 2018 | 0.1844M |
March 31, 2018 | 0.313M |
December 31, 2017 | 0.3293M |
September 30, 2017 | 0.3585M |
June 30, 2017 | 0.3419M |
March 31, 2017 | 0.2222M |
December 31, 2016 | 0.2241M |
September 30, 2016 | 0.1253M |
June 30, 2016 | 0.1168M |
March 31, 2016 | 0.2203M |
December 31, 2015 | 0.2101M |
September 30, 2015 | 0.2721M |
June 30, 2015 | 0.2886M |
March 31, 2015 | 0.2083M |
December 31, 2014 | 0.1893M |
September 30, 2014 | 0.1064M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.0654M
Minimum
Dec 2022
0.598M
Maximum
Jun 2019
0.2169M
Average
0.1936M
Median
Mar 2020
Revenue (TTM) Benchmarks
BioXcel Therapeutics Inc | 1.38M |
Assertio Holdings Inc | 152.07M |
Verastem Inc | -- |
Ocular Therapeutix Inc | 58.44M |
PAVmed Inc | 2.452M |